해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 11.08. (금)

구분	보고서(영문)
제약/바이오/임상시험 (8건)	Second Alzheimer’s Drug Rejected by NICE on the Same Day It Is Approved in the UK
	EU Critical Medicines Act: Proposal Is One Step Closer to Ending Overreliance on Asian Manufacturers
	Roche to Leverage Dyno Therapeutics Tech for Novel Gene Therapies in Neurological Disorders
	Strategic Intelligence: Big Data in Pharma 2024
	Strategic Intelligence: Digital Transformation and Emerging Technologies in the Healthcare Industry – 2024 Edition
	Bio/Pharmaceutical Outsourcing Report, October 2024
	Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes
	Top 20 Biopharmas’ Market Cap Rises 2% in Q3 2024 Amid Flurry of Drug Approvals
컨퍼런스/ 심포지엄/ 학회/기타 (4건)	IDWeek 2024: Prevention and Treatment for HIV – Clinical Trials and Policy Challenges
	IDWeek 2024: Kalihinol Analog Shows Promise as a Targeted Antimalarial Therapy
	IDWeek 2024: The Efficacy of SCY-247 in Murine Models of Invasive Fungal Infections
	Digital Marketing Trends in Non-small Cell Lung Cancer
질환별 (4건)	Glaucoma: Epidemiology Forecast to 2033
	COPD: 68-Market Analysis and Sales Forecast
	Recent Popularity of JAK Inhibitors in Atopic Dermatitis
	Glomerulonephritis: Competitive Landscape